Table 1.

Characteristics of control subjects and case subjects with t(14;18)-positive and t(14;18)-negative non-Hodgkin lymphoma (NHL)




Case subjects
Characteristic
Control subjects, no. (%)
t(14;18)-positive, no. (%)
t(14;18)-negative, no. (%)
Sex    
    Male   725 (50.6)   33 (50.8)   43 (40.2)  
    Female   707 (49.4)   32 (49.2)   64 (59.8)  
Respondent status    
    Self   808 (56.4)   40 (61.5)   60 (56.1)  
    Proxy   624 (43.6)   25 (38.5)   47 (43.9)  
Used tobacco products    
    Never   677 (47.3)   38 (58.5)   51 (47.7)  
    Ever   749 (52.3)   27 (41.5)   56 (52.3)  
Used hair dye    
    Never   976 (71.1)   48 (73.9)   70 (65.4)  
    Ever   386 (28.1)   17 (26.2)   37 (34.6)  
Family history of cancer    
    No   908 (64.6)   32 (50.8)   62 (59.6)  
    Nonhematopoietic cancer   419 (29.8)   25 (39.7)   31 (29.8)  
    Hematopoietic cancer   78 (5.6)   6 (9.5)   11 (10.6)  
WHO-defined histologic types    
    Follicular lymphoma   NA   42   21  
    Diffuse large B-cell lymphoma   NA   21   44  
    Small lymphocytic lymphoma   NA   1   17  
    Other*
 
NA
 
1
 
25
 



Case subjects
Characteristic
Control subjects, no. (%)
t(14;18)-positive, no. (%)
t(14;18)-negative, no. (%)
Sex    
    Male   725 (50.6)   33 (50.8)   43 (40.2)  
    Female   707 (49.4)   32 (49.2)   64 (59.8)  
Respondent status    
    Self   808 (56.4)   40 (61.5)   60 (56.1)  
    Proxy   624 (43.6)   25 (38.5)   47 (43.9)  
Used tobacco products    
    Never   677 (47.3)   38 (58.5)   51 (47.7)  
    Ever   749 (52.3)   27 (41.5)   56 (52.3)  
Used hair dye    
    Never   976 (71.1)   48 (73.9)   70 (65.4)  
    Ever   386 (28.1)   17 (26.2)   37 (34.6)  
Family history of cancer    
    No   908 (64.6)   32 (50.8)   62 (59.6)  
    Nonhematopoietic cancer   419 (29.8)   25 (39.7)   31 (29.8)  
    Hematopoietic cancer   78 (5.6)   6 (9.5)   11 (10.6)  
WHO-defined histologic types    
    Follicular lymphoma   NA   42   21  
    Diffuse large B-cell lymphoma   NA   21   44  
    Small lymphocytic lymphoma   NA   1   17  
    Other*
 
NA
 
1
 
25
 

For control subjects, n = 1432; for t(14;18)-positive case subjects, n = 65; for t(14;18)-negative case subjects, n = 107 (numbers in table may not sum to overall totals because of missing data).

NA indicates not applicable.

*

Other includes Burkitt-like NHL (n = 1), lymphoplasmacytic NHL (n = 2), mantle cell NHL (n = 4), marginal zone NHL (n = 4), plasmacytoma (n = 2), unclassifiable B-cell NHL (n = 1), and T-cell NHL (n = 12).

or Create an Account

Close Modal
Close Modal